 Cholangiocarcinoma
"Cholangiocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant tumor arising from the epithelium of the BILE DUCTS.
| Descriptor ID |
D018281
|
| MeSH Number(s) |
C04.557.470.200.025.450
|
| Concept/Terms |
Cholangiocarcinoma- Cholangiocarcinoma
- Cholangiocarcinomas
- Cholangiocellular Carcinoma
- Carcinoma, Cholangiocellular
- Carcinomas, Cholangiocellular
- Cholangiocellular Carcinomas
Extrahepatic Cholangiocarcinoma- Extrahepatic Cholangiocarcinoma
- Cholangiocarcinoma, Extrahepatic
- Cholangiocarcinomas, Extrahepatic
- Extrahepatic Cholangiocarcinomas
Intrahepatic Cholangiocarcinoma- Intrahepatic Cholangiocarcinoma
- Cholangiocarcinoma, Intrahepatic
- Cholangiocarcinomas, Intrahepatic
- Intrahepatic Cholangiocarcinomas
|
Below are MeSH descriptors whose meaning is more general than "Cholangiocarcinoma".
Below are MeSH descriptors whose meaning is more specific than "Cholangiocarcinoma".
This graph shows the total number of publications written about "Cholangiocarcinoma" by people in this website by year, and whether "Cholangiocarcinoma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 2001 | 0 | 1 | 1 | | 2004 | 0 | 1 | 1 | | 2005 | 1 | 0 | 1 | | 2006 | 1 | 1 | 2 | | 2007 | 3 | 0 | 3 | | 2008 | 2 | 0 | 2 | | 2009 | 1 | 0 | 1 | | 2010 | 0 | 2 | 2 | | 2011 | 4 | 1 | 5 | | 2012 | 3 | 1 | 4 | | 2013 | 7 | 0 | 7 | | 2014 | 2 | 0 | 2 | | 2015 | 3 | 0 | 3 | | 2016 | 0 | 2 | 2 | | 2018 | 3 | 0 | 3 | | 2019 | 3 | 0 | 3 | | 2020 | 2 | 0 | 2 | | 2021 | 6 | 0 | 6 | | 2022 | 1 | 0 | 1 | | 2023 | 3 | 0 | 3 | | 2024 | 7 | 1 | 8 | | 2025 | 6 | 0 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Cholangiocarcinoma" by people in Profiles.
-
Kawashima J, Akabane M, Khalil M, Woldesenbet S, Endo Y, Sahara K, Cauchy F, Aucejo F, Marques HP, Lopes R, Rodriguea A, Hugh T, Shen F, Maithel SK, Groot Koerkamp B, Popescu I, Kitago M, Weiss MJ, Martel G, Pulitano C, Aldrighetti L, Poultsides G, Ruzzenente A, Bauer TW, Gleisner A, Endo I, Pawlik TM. Tumour burden predicts outcomes after curative resection of multifocal intrahepatic cholangiocarcinoma. Br J Surg. 2025 Mar 28; 112(4).
-
Kawashima J, Endo Y, Woldesenbet S, Khalil M, Akabane M, Cauchy F, Shen F, Maithel S, Popescu I, Kitago M, Weiss MJ, Martel G, Pulitano C, Aldrighetti L, Poultsides G, Ruzzente A, Bauer TW, Gleisner A, Marques H, Koerkamp BG, Endo I, Pawlik TM. Recurrence-Free Survival as a Surrogate for Overall Survival Among Patients with Intrahepatic Cholangiocarcinoma Following Upfront Surgery: An International Multi-institutional Analysis. Ann Surg Oncol. 2025 Jul; 32(7):4967-4975.
-
Merkow RP, Cavnar MJ, Gleisner AL, Mayo SC, Gholami S, Karanicolas PJ, Koerkamp BG, Homs MYV, Connell LC, Cercek A, Helft PR, Polite BN, Patel RA, Uronis HE, D'Angelica M, Lidsky ME. Minimum Requirements to Safely Establish and Sustain New Hepatic Arterial Infusion Pump Programs: An International Expert Perspective. Ann Surg Oncol. 2025 Jun; 32(6):4408-4416.
-
Kawashima J, Endo Y, Woldesenbet S, Khalil M, Akabane M, Cauchy F, Shen F, Maithel S, Popescu I, Kitago M, Weiss MJ, Martel G, Pulitano C, Aldrighetti L, Poultsides G, Ruzzente A, Bauer TW, Gleisner A, Marques H, Groot Koerkamp B, Endo I, Pawlik TM. The Influence of Tumor Burden Score and Lymph Node Metastasis on the Survival Benefit of Adjuvant Chemotherapy in Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2025 Jun; 32(6):4341-4351.
-
Kawashima J, Akabane M, Endo Y, Woldesenbet S, Khalil M, Sahara K, Ruzzenente A, Aldrighetti L, Bauer TW, Marques HP, Lopes R, Oliveira S, Martel G, Popescu I, Weiss MJ, Kitago M, Poultsides G, Sasaki K, Maithel SK, Hugh T, Gleisner A, Aucejo F, Pulitano C, Shen F, Cauchy F, Groot Koerkamp B, Endo I, Pawlik TM. A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size. Ann Surg Oncol. 2025 May; 32(5):3505-3515.
-
Kawashima J, Endo Y, Woldesenbet S, Khalil M, Akabane M, Cauchy F, Shen F, Maithel S, Popescu I, Kitago M, Weiss MJ, Martel G, Pulitano C, Aldrighetti L, Poultsides G, Ruzzente A, Bauer TW, Gleisner A, Marques H, Groot Koerkamp B, Endo I, Pawlik TM. "Biological R2" resection for intrahepatic cholangiocarcinoma: identification of patients at risk for poor oncologic outcomes after curative-intent resection. HPB (Oxford). 2025 May; 27(5):619-629.
-
Altaf A, Munir MM, Khan MMM, Rashid Z, Khalil M, Guglielmi A, Ratti F, Aldrighetti L, Bauer TW, Marques HP, Martel G, Alexandrescu S, Weiss MJ, Kitago M, Poultsides G, Maithel SK, Pulitano C, Lam V, Popescu I, Gleisner A, Hugh T, Shen F, Cauchy F, Koerkamp BG, Endo I, Pawlik TM. Machine learning based prediction model for bile leak following hepatectomy for liver cancer. HPB (Oxford). 2025 Apr; 27(4):489-501.
-
Catalano G, Alaimo L, Chatzipanagiotou OP, Ruzzenente A, Aucejo F, Marques HP, Lam V, Hugh T, Bhimani N, Maithel SK, Kitago M, Endo I, Martel G, Pulitano C, Shen F, Popescu I, Koerkamp BG, Bauer TW, Cauchy F, Poultsides GA, Weiss M, Gleisner A, Pawlik TM. Prognostic value of the advanced lung cancer inflammation index in intrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2024 Dec; 50(12):108773.
-
Olthof PB, Bouwense SAW, Bednarsch J, Dewulf M, Kazemier G, Maithel S, Jarnagin WR, Aldrighetti L, Roberts KJ, Troisi RI, Malago MM, Lang H, Alikhanov R, Ruzzenente A, Malik H, Charco R, Sparrelid E, Pratschke J, Cescon M, Nadalin S, Hagendoorn J, Schadde E, Hoogwater FJH, Schnitzbauer AA, Topal B, Lodge P, Olde Damink SWM, Neumann UP, Groot Koerkamp B. Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort. Ann Surg Oncol. 2025 Mar; 32(3):1762-1768.
-
Villard C, Widman L, Sparrelid E, Bergquist A, Hagstr?m H. The risk of cholangiocarcinoma in patients with MASLD is not increased compared to the general population. Scand J Gastroenterol. 2024 11; 59(11):1249-1251.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|